-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NrnpXHtcuDLKncygFM3BG+9mHRkS/sicrIceh6Am37eJ4PvJc662pqvEKyY8oEHj +hRu5b7KH5gg6eG2T+r9Vw== 0000891554-97-000973.txt : 19971022 0000891554-97-000973.hdr.sgml : 19971022 ACCESSION NUMBER: 0000891554-97-000973 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19971008 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 19971021 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: EZ EM INC CENTRAL INDEX KEY: 0000727008 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 111999504 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-11479 FILM NUMBER: 97698551 BUSINESS ADDRESS: STREET 1: 717 MAIN ST CITY: WESTBURY STATE: NY ZIP: 11690 BUSINESS PHONE: 5163338230 8-K 1 CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 8, 1997 --------------------------------- Date of Report (Date of earliest event reported) E-Z-EM, Inc. ------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 1-11479 11-1999504 ---------------------------- ------------ ------------------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 717 Main Street, Westbury, New York 11590 ---------------------------------------- ---------- (Address of principal executive offices) (Zip Code) (516) 333-8230 ------------------------------- (Registrant's telephone number, including area code) Not Applicable ------------------------------------------------------------- (Former name or former address, if changed since last report) Page 1 of 3 Exhibit Index on Page 2 Item 5. Other Events ------------ On October 8, 1997, E-Z-EM, Inc. (the "Company") issued a press release concerning the resignation of the Company's President, Chief Executive Officer and Director, Mr. Daniel R. Martin. A copy of the press release is attached hereto as exhibit 99.1. Item 7. Financial Statements and Exhibits --------------------------------- (a) Financial statements of businesses acquired Not applicable (b) Pro forma financial information Not applicable (c) Exhibits No. Description Page -- ----------- ---- 99.1 Press Release dated October 8, 1997 3 issued by the Company SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. E-Z-EM, Inc. ----------------------------------- (Registrant) Date October 20, 1997 /s/ Dennis J. Curtin -------------------- ----------------------------------- Dennis J. Curtin, Vice President- Chief Financial Officer EX-99.1 2 PRESS RELEASE Exhibit 99.1 PRESS RELEASE ============================================================================ October 8, 1997 E-Z-EM, INC. PRESS RELEASE E-Z-EM BOARD ANNOUNCES THE RESIGNATION OF PRESIDENT AND CEO DANIEL R. MARTIN WESTBURY, NY, OCTOBER 8, 1997 E-Z-EM today announced that Daniel R. Martin, after consultation with E-Z-EM's board of directors, has resigned his position as President, Chief Executive Officer and Director in order to pursue another opportunity. The Board of Directors has retained Korn Ferry International, an executive search firm to initiate a search for a new President/CEO. Heading the search for a new CEO will be a committee composed of Board Vice Chairman Paul Echenberg, E-Z-EM Board members David P. Meyers, Donald A. Meyer and Chairman of the Board Howard S. Stern. Until a new CEO is hired, Mr. Stern will assume additional responsibilities for the Company's day-to- day operations working closely with the board and the executive management team. According to Mr. Stern, "Speaking for the entire Board, we are committed to expanding and diversifying E-Z-EM's contrast media business through continued licensing, accelerating new product development and line extensions as well as searching for additional product licensing and acquisition opportunities." E-Z-EM is the world's largest manufacturer of contrast agents for gastrointestinal radiology, and has major divisions engaged in interventional radiology and diagnostics. For additional information, please contact Howard S. Stern at (516) 333-8230. -----END PRIVACY-ENHANCED MESSAGE-----